Human Immunoglobulin G [EPC]

Human Immunoglobulin G [EPC] was reported 21060 times

Drugs of the Human Immunoglobulin G [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI A ANTIBODY POSITIVE 43 0.7818
1 MISLEADING LABORATORY TEST RESULT 56 0.6747
2 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 120 0.6383
3 ALLERGY TO IMMUNOGLOBULIN THERAPY 64 0.5872
4 RHESUS ANTIBODIES POSITIVE 65 0.5856
5 INFUSION SITE URTICARIA 279 0.4164
6 INFUSION SITE MASS 427 0.3928
7 ADMINISTRATION SITE SWELLING 121 0.3723
8 INFUSION SITE PRURITUS 1094 0.3464
9 INFUSION SITE BRUISING 712 0.3293
10 BLOOD IMMUNOGLOBULIN G ABNORMAL 54 0.3234
11 HEPATITIS B CORE ANTIBODY POSITIVE 120 0.3183
12 INFUSION SITE SCAR 137 0.3093
13 ADMINISTRATION SITE ERYTHEMA 87 0.3053
14 HEPATITIS B SURFACE ANTIBODY POSITIVE 87 0.2979
15 INFUSION SITE NODULE 286 0.2976
16 COOMBS DIRECT TEST POSITIVE 91 0.2917
17 INFUSION SITE SWELLING 1818 0.2886
18 TRANSFUSION-RELATED ACUTE LUNG INJURY 88 0.2857
19 INSPIRATORY CAPACITY DECREASED 79 0.2852
20 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 367 0.2552
21 INFUSION SITE DISCHARGE 446 0.2541
22 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 85 0.2530
23 INFUSION SITE ERYTHEMA 1825 0.2163
24 INFUSION SITE HAEMORRHAGE 703 0.2135
25 INFUSION SITE RASH 284 0.2068
26 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 50 0.2066
27 INFUSION SITE DISCOMFORT 214 0.2064
28 AMAUROSIS FUGAX 213 0.1978
29 INFUSION SITE WARMTH 238 0.1941
30 MALABSORPTION FROM INJECTION SITE 60 0.1935
31 MENINGITIS ASEPTIC 867 0.1929
32 IMMUNOGLOBULINS DECREASED 249 0.1812
33 BLOOD IMMUNOGLOBULIN G DECREASED 444 0.1790
34 IMMUNOGLOBULINS ABNORMAL 46 0.1762
35 ENCEPHALITIS CYTOMEGALOVIRUS 77 0.1758
36 INFUSION SITE VESICLES 87 0.1654
37 STIFF PERSON SYNDROME 55 0.1585
38 BLOOD IMMUNOGLOBULIN A DECREASED 103 0.1582
39 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 190 0.1526
40 INFUSION SITE PAIN 1939 0.1503
41 INFUSION SITE INDURATION 221 0.1490
42 INCORRECT DRUG ADMINISTRATION RATE 626 0.1469
43 INFUSION SITE IRRITATION 185 0.1440
44 ADMINISTRATION SITE REACTION 54 0.1399
45 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 62 0.1351
46 BODY HEIGHT BELOW NORMAL 85 0.1322
47 INFUSION SITE OEDEMA 110 0.1316
48 INFUSION SITE EXTRAVASATION 817 0.1311
49 INFUSION SITE DISCOLOURATION 110 0.1250
50 ANKLE ARTHROPLASTY 45 0.1240
51 INFUSION SITE REACTION 362 0.1211
52 IMMUNODEFICIENCY COMMON VARIABLE 56 0.1148
53 BLOOD IMMUNOGLOBULIN G INCREASED 139 0.1143
54 TRANSFUSION REACTION 100 0.1140
55 DEVICE INFUSION ISSUE 277 0.1116
56 JOINT DESTRUCTION 158 0.1015
57 INFUSION SITE HAEMATOMA 46 0.0966
58 MENINGISM 43 0.0917
59 IMMUNISATION REACTION 66 0.0917
60 ADMINISTRATION SITE PAIN 105 0.0911
61 IMMUNOGLOBULINS INCREASED 42 0.0901
62 INFUSION SITE INFLAMMATION 61 0.0864
63 SPUTUM PURULENT 56 0.0851
64 INSURANCE ISSUE 1283 0.0838
65 ANTIBODY TEST POSITIVE 132 0.0795
66 BLOOD IMMUNOGLOBULIN M DECREASED 79 0.0788
67 POST-ACUTE COVID-19 SYNDROME 88 0.0710
68 MULTIPLE ALLERGIES 508 0.0647
69 COVID-19 IMMUNISATION 54 0.0647
70 LOCAL REACTION 46 0.0621
71 ADMINISTRATION SITE EXTRAVASATION 62 0.0621
72 EPSTEIN-BARR VIRAEMIA 68 0.0613
73 SINUSITIS BACTERIAL 64 0.0607
74 MYASTHENIC SYNDROME 45 0.0581
75 SECONDARY IMMUNODEFICIENCY 70 0.0576
76 CROUP INFECTIOUS 42 0.0533
77 INFECTED BITE 45 0.0530
78 POOR VENOUS ACCESS 546 0.0527
79 NOROVIRUS INFECTION 75 0.0519
80 HAEMOLYSIS 390 0.0505
81 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 107 0.0464
82 SINUSITIS 4681 0.0456
83 URINARY TRACT DISORDER 203 0.0450
84 POLYARTHRITIS 235 0.0445
85 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 59 0.0437
86 MAST CELL ACTIVATION SYNDROME 61 0.0434
87 MYASTHENIA GRAVIS CRISIS 64 0.0432
88 CHRONIC SINUSITIS 162 0.0431
89 JUVENILE IDIOPATHIC ARTHRITIS 105 0.0429
90 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 55 0.0418
91 ENCEPHALITIS AUTOIMMUNE 53 0.0403
92 SEASONAL ALLERGY 560 0.0395
93 EAR INFECTION 1042 0.0391
94 HAEMOLYTIC ANAEMIA 350 0.0390
95 VEIN RUPTURE 63 0.0376
96 INFUSION SITE INFECTION 86 0.0370
97 INFUSION RELATED REACTION 2437 0.0367
98 CYTOMEGALOVIRUS INFECTION REACTIVATION 162 0.0366
99 INJECTION SITE OEDEMA 63 0.0366
100 PNEUMONIA PSEUDOMONAL 56 0.0365
101 PRODUCT DISTRIBUTION ISSUE 338 0.0364
102 RECALLED PRODUCT ADMINISTERED 346 0.0362
103 MENINGITIS VIRAL 49 0.0357
104 RESPIRATORY TRACT INFECTION 914 0.0351
105 CYTOMEGALOVIRUS VIRAEMIA 155 0.0348
106 TREATMENT DELAYED 60 0.0347
107 MYASTHENIA GRAVIS 275 0.0340
108 RESPIRATORY TRACT INFECTION VIRAL 79 0.0339
109 DRUG SPECIFIC ANTIBODY 46 0.0336
110 DERMATITIS CONTACT 380 0.0333
111 MENINGITIS 222 0.0332
112 LIVEDO RETICULARIS 69 0.0330
113 IMMUNE THROMBOCYTOPENIA 151 0.0329
114 OBSTRUCTION 131 0.0328
115 BK VIRUS INFECTION 108 0.0320
116 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 84 0.0316
117 DERMATOMYOSITIS 80 0.0315
118 LYME DISEASE 105 0.0315
119 GASTROENTERITIS VIRAL 567 0.0314
120 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 73 0.0311
121 HAEMORRHAGIC STROKE 241 0.0308
122 WHEELCHAIR USER 137 0.0308
123 HYPOGAMMAGLOBULINAEMIA 202 0.0307
124 UPPER RESPIRATORY TRACT INFECTION 1419 0.0307
125 RHINOVIRUS INFECTION 113 0.0290
126 HAEMATOLOGICAL INFECTION 71 0.0290
127 BRONCHIECTASIS 195 0.0289
128 ANAPHYLACTOID REACTION 118 0.0286
129 PNEUMONIA CYTOMEGALOVIRAL 54 0.0278
130 LYMPHADENITIS 67 0.0276
131 RESPIRATORY SYNCYTIAL VIRUS INFECTION 236 0.0271
132 SKIN INFECTION 299 0.0266
133 AUTOIMMUNE HAEMOLYTIC ANAEMIA 90 0.0262
134 DRUG TOLERANCE 132 0.0261
135 BODY TEMPERATURE ABNORMAL 48 0.0260
136 IMMUNE-MEDIATED MYOSITIS 71 0.0257
137 STREPTOCOCCAL INFECTION 141 0.0253
138 PHARYNGITIS STREPTOCOCCAL 273 0.0252
139 GENERALISED OEDEMA 311 0.0251
140 CHILLS 2913 0.0248
141 BRONCHITIS 1817 0.0245
142 PRODUCT SUPPLY ISSUE 175 0.0245
143 ATYPICAL PNEUMONIA 73 0.0244
144 CYSTITIS HAEMORRHAGIC 98 0.0243
145 FINE MOTOR SKILL DYSFUNCTION 69 0.0238
146 PSEUDOMONAS INFECTION 204 0.0238
147 ADRENAL INSUFFICIENCY 288 0.0237
148 OCULAR DISCOMFORT 266 0.0237
149 VIRAL INFECTION 787 0.0236
150 INFECTIOUS MONONUCLEOSIS 53 0.0236
151 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 50 0.0235
152 WEIGHT FLUCTUATION 238 0.0227
153 PHOTOPHOBIA 423 0.0225
154 EPSTEIN-BARR VIRUS INFECTION 139 0.0222
155 LIQUID PRODUCT PHYSICAL ISSUE 162 0.0222
156 TACHYPNOEA 297 0.0218
157 GASTROINTESTINAL INFECTION 195 0.0217
158 ADENOVIRUS INFECTION 63 0.0217
159 CHRONIC LYMPHOCYTIC LEUKAEMIA 103 0.0217
160 AUTOIMMUNE DISORDER 210 0.0215
161 SUSPECTED OFF LABEL USE 97 0.0215
162 EYE INFECTION 241 0.0213
163 SINUS DISORDER 421 0.0212
164 VARICELLA ZOSTER VIRUS INFECTION 44 0.0212
165 RESPIRATORY RATE INCREASED 188 0.0212
166 SUSPECTED COVID-19 69 0.0209
167 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1147 0.0209
168 THERAPY CHANGE 204 0.0207
169 INABILITY TO AFFORD MEDICATION 206 0.0207
170 PARANASAL SINUS DISCOMFORT 78 0.0206
171 URINE OUTPUT DECREASED 180 0.0206
172 COVID-19 PNEUMONIA 243 0.0206
173 BODY TEMPERATURE INCREASED 419 0.0205
174 MULTIPLE-DRUG RESISTANCE 63 0.0203
175 VASCULAR DEVICE INFECTION 92 0.0203
176 SINUS OPERATION 48 0.0201
177 PNEUMONIA FUNGAL 78 0.0198
178 SERUM SICKNESS 55 0.0197
179 KIDNEY INFECTION 387 0.0197
180 TOOTH INFECTION 259 0.0196
181 ANIMAL BITE 52 0.0195
182 PNEUMONIA BACTERIAL 179 0.0195
183 INFECTION 2813 0.0194
184 ASPERGILLUS INFECTION 127 0.0193
185 ELECTRIC SHOCK SENSATION 54 0.0193
186 AUTOIMMUNE THYROIDITIS 72 0.0190
187 RHEUMATOID FACTOR POSITIVE 109 0.0189
188 FOOD POISONING 101 0.0188
189 GUILLAIN-BARRE SYNDROME 91 0.0188
190 INJECTION SITE DISCHARGE 101 0.0188
191 HEAD DISCOMFORT 332 0.0187
192 GASTROINTESTINAL TOXICITY 90 0.0187
193 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 140 0.0186
194 C-REACTIVE PROTEIN ABNORMAL 119 0.0185
195 HYPERVOLAEMIA 91 0.0184
196 IMMUNODEFICIENCY 274 0.0184
197 ILLNESS 1887 0.0183
198 GASTRIC INFECTION 69 0.0180
199 ORAL INFECTION 70 0.0179
200 PNEUMONIA VIRAL 57 0.0179
201 TRANSPLANT REJECTION 142 0.0177
202 SKIN LACERATION 192 0.0176
203 NO ADVERSE EVENT 3199 0.0176
204 ANTINUCLEAR ANTIBODY POSITIVE 57 0.0175
205 OXYGEN SATURATION ABNORMAL 49 0.0172
206 CREPITATIONS 51 0.0171
207 FOETAL GROWTH RESTRICTION 104 0.0171
208 INJECTION SITE INFECTION 56 0.0170
209 CYTOMEGALOVIRUS INFECTION 283 0.0170
210 ARTHROPOD BITE 126 0.0170
211 VEIN DISORDER 85 0.0170
212 COVID-19 2978 0.0170
213 HEPATITIS B 101 0.0167
214 BACTERIAL INFECTION 308 0.0165
215 INJECTION SITE SCAR 46 0.0161
216 TENDERNESS 168 0.0161
217 FOOD ALLERGY 124 0.0160
218 ENCEPHALITIS 111 0.0160
219 PRODUCT TEMPERATURE EXCURSION ISSUE 82 0.0159
220 PRODUCT LEAKAGE 89 0.0158
221 ESCHERICHIA INFECTION 130 0.0158
222 CANDIDA INFECTION 265 0.0157
223 RHINITIS 126 0.0156
224 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 111 0.0155
225 SKIN ABRASION 73 0.0154
226 AUTONOMIC NERVOUS SYSTEM IMBALANCE 45 0.0154
227 LOCALISED INFECTION 362 0.0150
228 MIGRAINE 1416 0.0148
229 POST PROCEDURAL INFECTION 120 0.0147
230 PHARYNGITIS 180 0.0145
231 BLOOD PRESSURE SYSTOLIC DECREASED 65 0.0143
232 ANAPHYLACTIC REACTION 781 0.0141
233 BRAIN FOG 219 0.0140
234 JOINT INJURY 297 0.0139
235 SYRINGE ISSUE 243 0.0139
236 CYSTITIS 442 0.0139
237 THERAPY NON-RESPONDER 619 0.0138
238 FOOT OPERATION 68 0.0137
239 URTICARIA 2293 0.0137
240 HORDEOLUM 59 0.0136
241 FEAR OF INJECTION 97 0.0136
242 STAPHYLOCOCCAL INFECTION 447 0.0135
243 FUNGAL INFECTION 451 0.0135
244 FOETAL DEATH 70 0.0135
245 OBESITY 214 0.0134
246 SINUS CONGESTION 181 0.0134
247 PHARYNGEAL SWELLING 131 0.0134
248 POSTOPERATIVE WOUND INFECTION 90 0.0133
249 OTITIS MEDIA 44 0.0133
250 PULMONARY TOXICITY 94 0.0133
251 TACHYCARDIA 1174 0.0132
252 NODULE 171 0.0131
253 CUSHINGOID 42 0.0131
254 CONCUSSION 101 0.0130
255 FLANK PAIN 122 0.0130
256 DERMATITIS EXFOLIATIVE GENERALISED 45 0.0129
257 DIPLOPIA 333 0.0128
258 PYREXIA 4435 0.0128
259 ENTEROCOCCAL INFECTION 61 0.0126
260 INFLUENZA 1407 0.0126
261 OXYGEN SATURATION DECREASED 706 0.0126
262 URINARY TRACT INFECTION 2140 0.0125
263 PRESYNCOPE 303 0.0124
264 HEADACHE 7801 0.0124
265 ARTHRITIS INFECTIVE 57 0.0123
266 RED BLOOD CELL SEDIMENTATION RATE INCREASED 135 0.0122
267 ALTERED STATE OF CONSCIOUSNESS 264 0.0122
268 TOOTH ABSCESS 124 0.0122
269 FUNGAL SKIN INFECTION 49 0.0121
270 NEPHROPATHY TOXIC 134 0.0119
271 BLOOD IRON DECREASED 141 0.0119
272 BLOOD PRESSURE INCREASED 1815 0.0119
273 HYPOXIA 417 0.0118
274 WALKING AID USER 78 0.0118
275 NEEDLE ISSUE 344 0.0118
276 PNEUMONIA 3797 0.0117
277 THERAPY INTERRUPTED 829 0.0116
278 VIRAL UPPER RESPIRATORY TRACT INFECTION 55 0.0116
279 PARANASAL SINUS HYPERSECRETION 44 0.0115
280 LIMB INJURY 313 0.0115
281 INJECTION SITE EXTRAVASATION 142 0.0115
282 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2061 0.0114
283 NASOPHARYNGITIS 2103 0.0114
284 ACUTE PULMONARY OEDEMA 64 0.0114
285 RASH VESICULAR 55 0.0114
286 LUNG INFECTION 175 0.0113
287 BLOOD PRESSURE ABNORMAL 223 0.0112
288 BRONCHOPULMONARY ASPERGILLOSIS 86 0.0111
289 LOWER RESPIRATORY TRACT INFECTION 504 0.0111
290 PARTIAL SEIZURES 58 0.0111
291 SPUTUM DISCOLOURED 105 0.0111
292 RESPIRATORY DISTRESS 305 0.0110
293 SPLENOMEGALY 129 0.0110
294 SERUM FERRITIN INCREASED 58 0.0110
295 FEELING COLD 306 0.0110
296 PRODUCT USE COMPLAINT 173 0.0110
297 UPPER-AIRWAY COUGH SYNDROME 90 0.0109
298 PARAESTHESIA ORAL 157 0.0109
299 CELLULITIS 548 0.0109
300 INFLUENZA LIKE ILLNESS 895 0.0109
301 PNEUMOCYSTIS JIROVECII PNEUMONIA 109 0.0108
302 SWELLING 1013 0.0108
303 THROMBOTIC MICROANGIOPATHY 105 0.0108
304 JOINT EFFUSION 74 0.0107
305 THROAT TIGHTNESS 290 0.0107
306 LIGAMENT SPRAIN 106 0.0107
307 INJECTION SITE SWELLING 821 0.0107
308 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 102 0.0107
309 KLEBSIELLA INFECTION 54 0.0107
310 ILL-DEFINED DISORDER 646 0.0106
311 SCAR 182 0.0106
312 PLEURISY 63 0.0106
313 LYMPHADENOPATHY 374 0.0106
314 PETECHIAE 110 0.0105
315 PRODUCTIVE COUGH 502 0.0105
316 BACTERAEMIA 124 0.0104
317 SEPTIC SHOCK 454 0.0104
318 LEUKAEMIA 98 0.0104
319 PRODUCT AVAILABILITY ISSUE 236 0.0104
320 STAPHYLOCOCCAL BACTERAEMIA 45 0.0103
321 SKIN MASS 69 0.0103
322 GRAFT VERSUS HOST DISEASE 74 0.0103
323 LYMPHOMA 159 0.0103
324 EAR DISORDER 47 0.0103
325 CLOSTRIDIUM DIFFICILE INFECTION 224 0.0103
326 HAEMATEMESIS 260 0.0102
327 BLOOD LACTIC ACID INCREASED 54 0.0102
328 OBSTRUCTIVE AIRWAYS DISORDER 114 0.0102
329 CYANOSIS 161 0.0102
330 KIDNEY TRANSPLANT REJECTION 49 0.0102
331 SENSITIVE SKIN 75 0.0102
332 SYNOVITIS 182 0.0101
333 HYPERTHERMIA 76 0.0099
334 BRONCHOSPASM 141 0.0099
335 SEPSIS 1101 0.0099
336 ASCITES 289 0.0098
337 MULTIPLE ORGAN DYSFUNCTION SYNDROME 278 0.0098
338 POST PROCEDURAL COMPLICATION 188 0.0098
339 PHLEBITIS 50 0.0098
340 INCORRECT PRODUCT ADMINISTRATION DURATION 211 0.0097
341 HYPOCALCAEMIA 184 0.0097
342 HEREDITARY ANGIOEDEMA 104 0.0097
343 PERONEAL NERVE PALSY 55 0.0097
344 CHEST DISCOMFORT 977 0.0095
345 SKIN REACTION 134 0.0095
346 HEART RATE ABNORMAL 53 0.0095
347 WHEEZING 563 0.0095
348 ASTHMA 1071 0.0095
349 RALES 55 0.0095
350 LUNG DISORDER 464 0.0095
351 FOOT FRACTURE 179 0.0094
352 RESPIRATORY TRACT CONGESTION 150 0.0094
353 EAR PAIN 183 0.0094
354 SYSTEMIC LUPUS ERYTHEMATOSUS 334 0.0094
355 PULMONARY FIBROSIS 180 0.0094
356 FOOT DEFORMITY 104 0.0094
357 PULMONARY THROMBOSIS 101 0.0093
358 HAND FRACTURE 65 0.0092
359 MASS 128 0.0091
360 CONJUNCTIVITIS 169 0.0091
361 NO THERAPEUTIC RESPONSE 111 0.0091
362 PRODUCT DOSE OMISSION ISSUE 2670 0.0091
363 NECK PAIN 507 0.0091
364 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 46 0.0090
365 INJECTION SITE INDURATION 117 0.0090
366 GESTATIONAL DIABETES 43 0.0090
367 LIMB DISCOMFORT 279 0.0090
368 WOUND INFECTION 98 0.0089
369 HERPES ZOSTER 514 0.0089
370 RESPIRATORY DISORDER 266 0.0089
371 PREGNANCY 178 0.0089
372 HYPOALBUMINAEMIA 69 0.0089
373 CONTUSION 854 0.0089
374 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 73 0.0088
375 HAEMATURIA 303 0.0088
376 INJECTION SITE DISCOMFORT 93 0.0088
377 BODY TEMPERATURE DECREASED 87 0.0088
378 MUSCULOSKELETAL DISCOMFORT 152 0.0088
379 PALLOR 239 0.0088
380 SINUS HEADACHE 52 0.0087
381 ORAL CANDIDIASIS 115 0.0087
382 FIBROMYALGIA 210 0.0086
383 INTRACRANIAL PRESSURE INCREASED 48 0.0086
384 OFF LABEL USE 7493 0.0085
385 ARTHRITIS 672 0.0085
386 NEPHROLITHIASIS 391 0.0085
387 FACIAL PAIN 76 0.0085
388 MOUTH SWELLING 49 0.0085
389 BLOOD PRESSURE DECREASED 564 0.0085
390 MUSCLE STRAIN 73 0.0084
391 SKIN WARM 49 0.0084
392 INTENTIONAL PRODUCT USE ISSUE 734 0.0084
393 LIP SWELLING 278 0.0083
394 BLOOD MAGNESIUM DECREASED 72 0.0083
395 COUGH 2338 0.0083
396 DIVERTICULITIS 231 0.0083
397 CYTOPENIA 102 0.0083
398 ENERGY INCREASED 49 0.0083
399 MYOSITIS 74 0.0082
400 VASCULITIS 96 0.0082
401 LYMPHOPENIA 116 0.0082
402 PULMONARY MASS 122 0.0082
403 NEURALGIA 199 0.0082
404 EYELID PTOSIS 83 0.0082
405 GINGIVITIS 44 0.0081
406 BLOOD PRESSURE DIASTOLIC DECREASED 60 0.0081
407 PRURITUS 3110 0.0081
408 OROPHARYNGEAL DISCOMFORT 73 0.0081
409 GASTROINTESTINAL DISORDER 719 0.0080
410 OROPHARYNGEAL PAIN 741 0.0080
411 INJECTION SITE PRURITUS 534 0.0080
412 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 233 0.0079
413 INJECTION SITE MASS 294 0.0079
414 PLATELET COUNT ABNORMAL 48 0.0079
415 PEMPHIGUS 99 0.0079
416 UROSEPSIS 73 0.0079
417 PRODUCT DOSE OMISSION IN ERROR 222 0.0078
418 HEPATOMEGALY 77 0.0078
419 IMMUNE SYSTEM DISORDER 103 0.0078
420 BLADDER DISORDER 77 0.0077
421 IMMUNOSUPPRESSION 68 0.0077
422 OSTEOMYELITIS 139 0.0077
423 MENISCUS INJURY 47 0.0076
424 MALAISE 3350 0.0076
425 BLINDNESS 311 0.0076
426 IMPAIRED GASTRIC EMPTYING 104 0.0076
427 INJECTION SITE ERYTHEMA 946 0.0076
428 THROMBOSIS 613 0.0076
429 ADVERSE REACTION 101 0.0076
430 PREMATURE DELIVERY 121 0.0076
431 HELICOBACTER INFECTION 78 0.0076
432 LYMPHOEDEMA 52 0.0075
433 FATIGUE 5849 0.0075
434 FEELING OF BODY TEMPERATURE CHANGE 44 0.0075
435 BACK DISORDER 122 0.0075
436 FULL BLOOD COUNT ABNORMAL 79 0.0075
437 RENAL PAIN 79 0.0074
438 SPINAL PAIN 87 0.0074
439 ASPIRATION 81 0.0074
440 SARS-COV-2 TEST POSITIVE 97 0.0073
441 PREMATURE BABY 221 0.0073
442 RIB FRACTURE 151 0.0073
443 TINNITUS 337 0.0073
444 FRUSTRATION TOLERANCE DECREASED 59 0.0073
445 RASH PRURITIC 395 0.0073
446 BACK INJURY 79 0.0073
447 WRIST FRACTURE 87 0.0073
448 PNEUMONIA ASPIRATION 181 0.0072
449 PERIPHERAL SWELLING 1112 0.0072
450 MUSCULOSKELETAL STIFFNESS 632 0.0072
451 COLD SWEAT 127 0.0072
452 BACK PAIN 1669 0.0072
453 DRUG INTOLERANCE 693 0.0072
454 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 372 0.0071
455 TOXIC EPIDERMAL NECROLYSIS 108 0.0071
456 PAPULE 50 0.0071
457 EXPOSURE DURING PREGNANCY 441 0.0071
458 HAND DEFORMITY 93 0.0071
459 NERVE COMPRESSION 65 0.0070
460 DEVICE RELATED INFECTION 108 0.0070
461 PRODUCT PREPARATION ISSUE 46 0.0070
462 THERAPY PARTIAL RESPONDER 109 0.0070
463 SPINAL OPERATION 86 0.0070
464 PULMONARY EMBOLISM 663 0.0070
465 ARTHROPATHY 387 0.0070
466 INJECTION SITE VESICLES 42 0.0069
467 EYE PAIN 391 0.0069
468 COMA 330 0.0069
469 HYPERSENSITIVITY 1282 0.0069
470 INJECTION SITE NODULE 76 0.0069
471 HEART RATE INCREASED 683 0.0069
472 THERAPEUTIC PRODUCT EFFECT DECREASED 308 0.0069
473 HEAD INJURY 216 0.0068
474 NASAL CONGESTION 401 0.0068
475 PRODUCT USE IN UNAPPROVED INDICATION 1690 0.0068
476 NEOPLASM MALIGNANT 454 0.0068
477 ABDOMINAL DISTENSION 710 0.0068
478 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 116 0.0068
479 THERMAL BURN 48 0.0068
480 THYROID DISORDER 104 0.0067
481 POLYP 44 0.0067
482 SPINAL FRACTURE 134 0.0067
483 CYST 83 0.0067
484 DYSPNOEA 3785 0.0067
485 TRANSIENT ISCHAEMIC ATTACK 225 0.0067
486 ERYTHEMA 1364 0.0066
487 WEIGHT DECREASED 1851 0.0066
488 CYTOKINE RELEASE SYNDROME 133 0.0066
489 HYPOKALAEMIA 306 0.0066
490 PANCYTOPENIA 370 0.0066
491 HERNIA 128 0.0066
492 HERPES SIMPLEX 43 0.0066
493 MUSCULAR WEAKNESS 750 0.0066
494 SCIATICA 105 0.0066
495 ATAXIA 78 0.0066
496 PELVIC FRACTURE 51 0.0065
497 SECRETION DISCHARGE 82 0.0065
498 BEDRIDDEN 86 0.0065
499 ROTATOR CUFF SYNDROME 84 0.0065
500 DISSEMINATED INTRAVASCULAR COAGULATION 92 0.0065
501 APHONIA 91 0.0065
502 RESPIRATORY FAILURE 475 0.0065
503 OEDEMA 353 0.0065
504 SWOLLEN TONGUE 203 0.0065
505 PRODUCT ADMINISTRATION INTERRUPTED 51 0.0065
506 GRIP STRENGTH DECREASED 57 0.0065
507 MUSCULOSKELETAL CHEST PAIN 100 0.0065
508 C-REACTIVE PROTEIN INCREASED 235 0.0065
509 BODY HEIGHT DECREASED 69 0.0064
510 FACIAL PARALYSIS 55 0.0064
511 FOETAL EXPOSURE DURING PREGNANCY 523 0.0064
512 HEPATOTOXICITY 143 0.0064
513 SKIN CANCER 138 0.0064
514 PRODUCT USE ISSUE 1203 0.0064
515 CARDIO-RESPIRATORY ARREST 267 0.0064
516 PRODUCT ADMINISTRATION ERROR 129 0.0064
517 ECZEMA 334 0.0064
518 FALL 2121 0.0064
519 HYPOAESTHESIA ORAL 96 0.0064
520 COAGULOPATHY 106 0.0064
521 DEEP VEIN THROMBOSIS 412 0.0063
522 WOUND 177 0.0063
523 MATERNAL EXPOSURE DURING PREGNANCY 562 0.0063
524 STATUS EPILEPTICUS 71 0.0063
525 LEUKOPENIA 314 0.0063
526 FLUSHING 633 0.0062
527 INJECTION SITE IRRITATION 79 0.0062
528 ANAPHYLACTIC SHOCK 160 0.0062
529 SNEEZING 139 0.0062
530 PERIPHERAL COLDNESS 85 0.0062
531 HYPERTRANSAMINASAEMIA 43 0.0062
532 BRAIN OEDEMA 78 0.0062
533 HYPERTENSION 1307 0.0062
534 CATARACT 366 0.0061
535 RHINORRHOEA 396 0.0061
536 RASH 2669 0.0061
537 BLOOD PRESSURE SYSTOLIC INCREASED 119 0.0061
538 HYPERAESTHESIA 50 0.0061
539 PNEUMOTHORAX 96 0.0060
540 TROPONIN INCREASED 46 0.0060
541 RASH PAPULAR 135 0.0060
542 CONTRAINDICATED PRODUCT ADMINISTERED 182 0.0060
543 THROAT IRRITATION 269 0.0060
544 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 287 0.0060
545 UPPER LIMB FRACTURE 119 0.0060
546 ORAL HERPES 116 0.0059
547 HYPERTENSIVE CRISIS 66 0.0059
548 HYPERSOMNIA 170 0.0059
549 RASH ERYTHEMATOUS 283 0.0059
550 NAUSEA 4631 0.0058
551 VOMITING 2746 0.0058
552 ROAD TRAFFIC ACCIDENT 244 0.0058
553 CHEST PAIN 1076 0.0058
554 DECREASED IMMUNE RESPONSIVENESS 57 0.0058
555 DRY THROAT 59 0.0058
556 DERMATITIS BULLOUS 42 0.0058
557 SCAB 66 0.0058
558 PURPURA 51 0.0058
559 CHROMATURIA 130 0.0058
560 GASTROENTERITIS 84 0.0058
561 BLISTER 322 0.0057
562 DRUG RESISTANCE 147 0.0057
563 HAEMATOMA 148 0.0057
564 ACUTE RESPIRATORY DISTRESS SYNDROME 101 0.0057
565 HEART RATE DECREASED 200 0.0057
566 BLOOD TEST ABNORMAL 80 0.0057
567 WEIGHT INCREASED 1275 0.0057
568 MYALGIA 968 0.0057
569 PLEURAL EFFUSION 346 0.0057
570 BLOOD SODIUM DECREASED 107 0.0057
571 REBOUND EFFECT 64 0.0057
572 INFLAMMATION 292 0.0057
573 PYELONEPHRITIS 49 0.0056
574 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 402 0.0056
575 POOR QUALITY SLEEP 121 0.0056
576 ANKLE FRACTURE 87 0.0056
577 ACUTE RESPIRATORY FAILURE 108 0.0056
578 RENAL DISORDER 261 0.0056
579 SPINAL DISORDER 53 0.0056
580 DERMATITIS ALLERGIC 70 0.0056
581 TOXIC SKIN ERUPTION 56 0.0056
582 IRRITABLE BOWEL SYNDROME 119 0.0055
583 RASH MACULAR 194 0.0055
584 INCREASED TENDENCY TO BRUISE 51 0.0055
585 LOW BIRTH WEIGHT BABY 44 0.0055
586 SYNCOPE 552 0.0055
587 APPENDICITIS 51 0.0055
588 ASTHENIA 2053 0.0055
589 SWELLING FACE 355 0.0054
590 POLYNEUROPATHY 65 0.0054
591 EMBOLISM 45 0.0054
592 PAIN 3319 0.0054
593 THERAPY CESSATION 276 0.0054
594 PLATELET COUNT DECREASED 569 0.0053
595 ELECTROLYTE IMBALANCE 62 0.0053
596 PHOTOSENSITIVITY REACTION 88 0.0053
597 TREMOR 884 0.0053
598 BLOOD URINE PRESENT 101 0.0053
599 PERICARDIAL EFFUSION 123 0.0053
600 NERVE INJURY 59 0.0053
601 HIP FRACTURE 170 0.0053
602 LETHARGY 304 0.0053
603 CARPAL TUNNEL SYNDROME 74 0.0053
604 ATELECTASIS 51 0.0053
605 BURSITIS 64 0.0053
606 ABSCESS 84 0.0053
607 ATRIAL FLUTTER 42 0.0053
608 TOOTH FRACTURE 58 0.0053
609 SKIN LESION 144 0.0052
610 THROMBOCYTOPENIA 586 0.0052
611 TREATMENT FAILURE 434 0.0052
612 PULMONARY CONGESTION 69 0.0052
613 PROCEDURAL PAIN 145 0.0052
614 INJECTION SITE URTICARIA 128 0.0052
615 ABDOMINAL PAIN 1213 0.0052
616 SQUAMOUS CELL CARCINOMA 49 0.0052
617 UNEVALUABLE EVENT 392 0.0052
618 BLOOD LACTATE DEHYDROGENASE INCREASED 82 0.0052
619 RASH MACULO-PAPULAR 115 0.0052
620 EAR DISCOMFORT 53 0.0052
621 FEELING HOT 316 0.0051
622 LOWER LIMB FRACTURE 99 0.0051
623 FOLLICULITIS 54 0.0051
624 QUALITY OF LIFE DECREASED 69 0.0051
625 HOSPITALISATION 788 0.0051
626 COLITIS 194 0.0051
627 JOINT DISLOCATION 54 0.0051
628 SLUGGISHNESS 52 0.0051
629 HYPOTENSION 1022 0.0051
630 PRODUCT PRESCRIBING ISSUE 110 0.0050
631 SHOCK 116 0.0050
632 DISCOMFORT 307 0.0050
633 MOBILITY DECREASED 361 0.0050
634 HEMIPARESIS 85 0.0050
635 PRODUCT CONTAINER ISSUE 43 0.0050
636 NEUROPATHY PERIPHERAL 476 0.0050
637 DYSPHONIA 292 0.0050
638 BRAIN INJURY 50 0.0050
639 LUNG INFILTRATION 44 0.0050
640 LOSS OF CONSCIOUSNESS 638 0.0050
641 DEVICE OCCLUSION 70 0.0050
642 GAIT INABILITY 165 0.0049
643 JOINT STIFFNESS 129 0.0049
644 GASTRIC ULCER 93 0.0049
645 GLOMERULAR FILTRATION RATE DECREASED 60 0.0049
646 BURNING SENSATION 342 0.0049
647 HYPOTHERMIA 49 0.0048
648 ABORTION SPONTANEOUS 193 0.0048
649 SEIZURE 556 0.0048
650 OSTEOPOROSIS 198 0.0048
651 NEUTROPENIA 654 0.0048
652 MOTOR DYSFUNCTION 49 0.0048
653 PAIN IN EXTREMITY 1413 0.0048
654 JOINT SWELLING 578 0.0048
655 HEPATIC ENZYME INCREASED 326 0.0048
656 ULCER 76 0.0048
657 DECREASED APPETITE 1108 0.0048
658 ANGIOEDEMA 210 0.0047
659 GOUT 85 0.0047
660 SLEEP APNOEA SYNDROME 90 0.0047
661 ARTHRALGIA 1957 0.0047
662 HAEMOGLOBIN DECREASED 483 0.0047
663 SUPRAVENTRICULAR TACHYCARDIA 45 0.0047
664 ACCIDENT 56 0.0047
665 DEHYDRATION 625 0.0047
666 SOMNOLENCE 943 0.0047
667 CONDITION AGGRAVATED 1421 0.0047
668 ANAL INCONTINENCE 42 0.0047
669 APHASIA 141 0.0047
670 RASH GENERALISED 120 0.0046
671 FEELING ABNORMAL 1110 0.0046
672 HAEMORRHAGE INTRACRANIAL 69 0.0046
673 NEOPLASM 53 0.0046
674 PLATELET COUNT INCREASED 60 0.0046
675 MYELOSUPPRESSION 165 0.0046
676 INTERNAL HAEMORRHAGE 52 0.0045
677 HYPERHIDROSIS 583 0.0045
678 IMPAIRED QUALITY OF LIFE 65 0.0045
679 CIRCULATORY COLLAPSE 77 0.0045
680 MUSCLE TIGHTNESS 73 0.0045
681 EPISTAXIS 337 0.0045
682 WHITE BLOOD CELL COUNT INCREASED 172 0.0045
683 HIATUS HERNIA 58 0.0045
684 COMPLICATION ASSOCIATED WITH DEVICE 65 0.0045
685 TOOTHACHE 81 0.0045
686 GASTROINTESTINAL PAIN 49 0.0044
687 CLOSTRIDIUM DIFFICILE COLITIS 47 0.0044
688 HYPOAESTHESIA 663 0.0044
689 LYMPHOCYTE COUNT DECREASED 78 0.0044
690 FLUID RETENTION 224 0.0044
691 PARALYSIS 63 0.0044
692 DIZZINESS 2194 0.0044
693 INJECTION SITE WARMTH 90 0.0044
694 BLOOD PRESSURE FLUCTUATION 105 0.0044
695 VERTIGO 266 0.0044
696 RESTLESS LEGS SYNDROME 79 0.0043
697 MUSCLE TWITCHING 100 0.0043
698 SKIN ULCER 112 0.0043
699 CARDIOGENIC SHOCK 62 0.0043
700 PRURITUS GENERALISED 93 0.0043
701 GLOSSODYNIA 96 0.0043
702 HYPERBILIRUBINAEMIA 44 0.0042
703 ACUTE HEPATIC FAILURE 58 0.0042
704 ADVERSE DRUG REACTION 380 0.0042
705 PHARYNGEAL OEDEMA 65 0.0042
706 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 108 0.0042
707 LIVER FUNCTION TEST ABNORMAL 122 0.0042
708 BLOOD POTASSIUM DECREASED 126 0.0042
709 MYOCARDITIS 48 0.0042
710 KNEE ARTHROPLASTY 88 0.0042
711 INJECTION SITE RASH 128 0.0042
712 BASAL CELL CARCINOMA 65 0.0042
713 CARDIAC DISORDER 388 0.0041
714 AGRANULOCYTOSIS 77 0.0041
715 ATRIAL FIBRILLATION 403 0.0041
716 CORONARY ARTERY DISEASE 125 0.0041
717 ENCEPHALOPATHY 101 0.0041
718 PARAESTHESIA 643 0.0041
719 MUSCLE SPASMS 750 0.0041
720 DEVICE ISSUE 364 0.0041
721 TOOTH DISORDER 90 0.0040
722 GALLBLADDER DISORDER 72 0.0040
723 CHOLECYSTECTOMY 46 0.0040
724 SKIN DISCOLOURATION 185 0.0040
725 DYSPHAGIA 382 0.0040
726 PULMONARY HYPERTENSION 83 0.0040
727 DIARRHOEA 2561 0.0040
728 INTERSTITIAL LUNG DISEASE 192 0.0040
729 CAESAREAN SECTION 46 0.0039
730 DRUG ERUPTION 70 0.0039
731 DYSARTHRIA 148 0.0039
732 GENERALISED TONIC-CLONIC SEIZURE 65 0.0039
733 ABDOMINAL PAIN UPPER 807 0.0039
734 HAEMOPTYSIS 109 0.0039
735 GENERAL PHYSICAL HEALTH DETERIORATION 452 0.0039
736 PLASMA CELL MYELOMA 152 0.0039
737 MUSCULOSKELETAL PAIN 203 0.0039
738 PERICARDITIS 65 0.0039
739 INJECTION SITE BRUISING 308 0.0039
740 EPILEPSY 118 0.0039
741 RENAL IMPAIRMENT 324 0.0039
742 DRUG EFFECT LESS THAN EXPECTED 57 0.0038
743 PULMONARY OEDEMA 172 0.0038
744 GASTROOESOPHAGEAL REFLUX DISEASE 309 0.0038
745 SKIN DISORDER 127 0.0038
746 BONE PAIN 223 0.0038
747 BONE DENSITY DECREASED 119 0.0038
748 INTERVERTEBRAL DISC PROTRUSION 83 0.0038
749 LIVER DISORDER 168 0.0038
750 ANAEMIA 720 0.0038
751 GASTRITIS 99 0.0038
752 VISION BLURRED 516 0.0038
753 ISCHAEMIC STROKE 67 0.0038
754 NEUTROPHIL COUNT DECREASED 153 0.0038
755 BLOOD BILIRUBIN INCREASED 101 0.0037
756 DYSPNOEA EXERTIONAL 140 0.0037
757 IMPAIRED WORK ABILITY 79 0.0037
758 UNRESPONSIVE TO STIMULI 95 0.0037
759 JAUNDICE 99 0.0037
760 RHEUMATOID ARTHRITIS 416 0.0037
761 NIGHT SWEATS 118 0.0037
762 SMALL INTESTINAL OBSTRUCTION 45 0.0037
763 FEEDING DISORDER 74 0.0036
764 ABDOMINAL DISCOMFORT 612 0.0036
765 DYSURIA 134 0.0036
766 DERMATITIS 76 0.0036
767 TASTE DISORDER 73 0.0036
768 LEUKOCYTOSIS 65 0.0036
769 MENTAL IMPAIRMENT 87 0.0036
770 TREATMENT NONCOMPLIANCE 196 0.0036
771 INJECTION SITE REACTION 246 0.0036
772 CENTRAL NERVOUS SYSTEM LESION 49 0.0036
773 HEPATIC CIRRHOSIS 67 0.0036
774 BLINDNESS UNILATERAL 50 0.0035
775 EYE SWELLING 131 0.0035
776 DIABETES MELLITUS 268 0.0035
777 GINGIVAL BLEEDING 48 0.0035
778 WHITE BLOOD CELL COUNT DECREASED 380 0.0035
779 IMPAIRED HEALING 115 0.0035
780 BALANCE DISORDER 302 0.0035
781 LIVER FUNCTION TEST INCREASED 75 0.0035
782 SPEECH DISORDER 183 0.0035
783 HEPATITIS C 42 0.0035
784 EATING DISORDER 74 0.0035
785 MULTI-ORGAN FAILURE 60 0.0035
786 NERVOUS SYSTEM DISORDER 108 0.0035
787 MYELODYSPLASTIC SYNDROME 50 0.0035
788 HAEMORRHAGE 361 0.0034
789 OSTEOARTHRITIS 146 0.0034
790 HEPATIC STEATOSIS 64 0.0034
791 MALIGNANT MELANOMA 46 0.0034
792 BRADYCARDIA 181 0.0034
793 PALPITATIONS 399 0.0034
794 INTENTIONAL DOSE OMISSION 97 0.0034
795 HEPATOCELLULAR INJURY 48 0.0034
796 INCORRECT DOSE ADMINISTERED 772 0.0034
797 GAIT DISTURBANCE 646 0.0034
798 MOUTH ULCERATION 71 0.0034
799 INJECTION SITE DISCOLOURATION 42 0.0034
800 FEELING JITTERY 64 0.0034
801 HEPATIC FAILURE 101 0.0033
802 SURGERY 196 0.0033
803 INTESTINAL OBSTRUCTION 125 0.0033
804 SENSORY DISTURBANCE 53 0.0033
805 PRODUCT STORAGE ERROR 289 0.0033
806 OEDEMA PERIPHERAL 402 0.0033
807 HEPATIC FUNCTION ABNORMAL 123 0.0033
808 RENAL FAILURE 437 0.0033
809 RED BLOOD CELL COUNT DECREASED 94 0.0033
810 MOVEMENT DISORDER 105 0.0033
811 CARDIOMYOPATHY 48 0.0032
812 PAIN IN JAW 92 0.0032
813 CEREBROVASCULAR ACCIDENT 542 0.0032
814 FEBRILE NEUTROPENIA 212 0.0032
815 BLOOD CREATININE INCREASED 207 0.0032
816 HEPATITIS 81 0.0032
817 UNDERDOSE 231 0.0032
818 BLOOD CREATINE PHOSPHOKINASE INCREASED 91 0.0032
819 DRUG INEFFECTIVE 4164 0.0032
820 ACUTE MYOCARDIAL INFARCTION 93 0.0032
821 HIP ARTHROPLASTY 48 0.0031
822 CHOKING 61 0.0031
823 ORAL PAIN 70 0.0031
824 POLLAKIURIA 130 0.0031
825 TENDONITIS 48 0.0031
826 VENTRICULAR TACHYCARDIA 51 0.0031
827 DYSSTASIA 90 0.0031
828 ASPARTATE AMINOTRANSFERASE INCREASED 163 0.0031
829 PRESCRIBED UNDERDOSE 61 0.0031
830 URINARY RETENTION 102 0.0031
831 MENTAL DISORDER 133 0.0031
832 HEART RATE IRREGULAR 69 0.0031
833 THERAPEUTIC RESPONSE SHORTENED 101 0.0030
834 URINARY INCONTINENCE 90 0.0030
835 PANCREATITIS 160 0.0030
836 GAMMA-GLUTAMYLTRANSFERASE INCREASED 67 0.0030
837 COLON CANCER 45 0.0030
838 ACUTE MYELOID LEUKAEMIA 47 0.0030
839 INJECTION SITE PAIN 925 0.0030
840 TRANSAMINASES INCREASED 67 0.0030
841 RESTLESSNESS 110 0.0030
842 INJECTION SITE HAEMORRHAGE 238 0.0030
843 MEMORY IMPAIRMENT 409 0.0030
844 DEATH 2564 0.0030
845 EOSINOPHILIA 52 0.0030
846 FACE OEDEMA 50 0.0030
847 SKIN EXFOLIATION 250 0.0030
848 GLAUCOMA 57 0.0030
849 EYE DISORDER 97 0.0029
850 CEREBRAL HAEMORRHAGE 105 0.0029
851 HAEMATOCRIT DECREASED 58 0.0029
852 DEPRESSED MOOD 153 0.0029
853 HYPOKINESIA 42 0.0029
854 ARRHYTHMIA 137 0.0029
855 ANXIETY 816 0.0029
856 SLEEP DISORDER 201 0.0028
857 INSOMNIA 758 0.0028
858 NERVOUSNESS 148 0.0028
859 FULL BLOOD COUNT DECREASED 57 0.0028
860 HYPOPHAGIA 72 0.0028
861 DEAFNESS 73 0.0028
862 DISABILITY 55 0.0028
863 VISUAL IMPAIRMENT 344 0.0028
864 MENTAL STATUS CHANGES 77 0.0028
865 DEMENTIA 76 0.0027
866 CARDIAC ARREST 224 0.0027
867 BLOOD GLUCOSE ABNORMAL 50 0.0027
868 COGNITIVE DISORDER 126 0.0027
869 BLOOD UREA INCREASED 45 0.0027
870 LABORATORY TEST ABNORMAL 79 0.0027
871 SKIN FISSURES 52 0.0027
872 CONFUSIONAL STATE 425 0.0026
873 DISEASE RECURRENCE 125 0.0026
874 RETCHING 56 0.0026
875 DISORIENTATION 103 0.0026
876 ACUTE KIDNEY INJURY 397 0.0026
877 ALANINE AMINOTRANSFERASE INCREASED 159 0.0026
878 LIVER INJURY 63 0.0026
879 HAEMORRHOIDS 50 0.0026
880 CRYING 93 0.0026
881 DISEASE PROGRESSION 299 0.0025
882 DRY EYE 126 0.0025
883 THIRST 45 0.0025
884 CARDIAC FAILURE 201 0.0025
885 HYPONATRAEMIA 141 0.0025
886 CHOLELITHIASIS 82 0.0025
887 PANIC ATTACK 91 0.0025
888 STOMATITIS 151 0.0025
889 PNEUMONITIS 67 0.0025
890 CEREBRAL INFARCTION 60 0.0025
891 LACRIMATION INCREASED 74 0.0024
892 SKIN IRRITATION 112 0.0024
893 PSORIASIS 318 0.0024
894 STEVENS-JOHNSON SYNDROME 54 0.0024
895 PRESCRIBED OVERDOSE 47 0.0024
896 DRY MOUTH 196 0.0024
897 CONSTIPATION 525 0.0024
898 DEVICE LEAKAGE 104 0.0024
899 DEVICE BREAKAGE 95 0.0023
900 DELIRIUM 81 0.0023
901 PRODUCT PHYSICAL ISSUE 47 0.0023
902 CARDIAC FAILURE CONGESTIVE 186 0.0023
903 IRRITABILITY 139 0.0023
904 HOT FLUSH 174 0.0023
905 HYPERGLYCAEMIA 83 0.0023
906 INJURY ASSOCIATED WITH DEVICE 46 0.0023
907 BLOOD ALKALINE PHOSPHATASE INCREASED 56 0.0023
908 ABDOMINAL PAIN LOWER 57 0.0023
909 GASTROINTESTINAL HAEMORRHAGE 187 0.0022
910 EYE PRURITUS 75 0.0022
911 ERUCTATION 43 0.0022
912 MYOCARDIAL INFARCTION 385 0.0022
913 DEPRESSED LEVEL OF CONSCIOUSNESS 87 0.0022
914 HAEMATOCHEZIA 121 0.0022
915 AGITATION 161 0.0022
916 METABOLIC ACIDOSIS 70 0.0022
917 PSORIATIC ARTHROPATHY 88 0.0022
918 FAECES DISCOLOURED 47 0.0022
919 PRODUCT QUALITY ISSUE 292 0.0021
920 DISTURBANCE IN ATTENTION 115 0.0021
921 BONE MARROW FAILURE 43 0.0021
922 DRUG EXPOSURE DURING PREGNANCY 71 0.0021
923 RENAL FAILURE ACUTE 88 0.0021
924 PRODUCT PRESCRIBING ERROR 49 0.0021
925 HYPOACUSIS 88 0.0020
926 OCULAR HYPERAEMIA 97 0.0020
927 HYPOTHYROIDISM 65 0.0020
928 FEMUR FRACTURE 63 0.0020
929 DYSPEPSIA 200 0.0020
930 RECTAL HAEMORRHAGE 87 0.0020
931 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 408 0.0020
932 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 68 0.0020
933 CARDIOVASCULAR DISORDER 51 0.0020
934 MELAENA 44 0.0020
935 AMNESIA 130 0.0020
936 ALOPECIA 392 0.0020
937 MUCOSAL INFLAMMATION 52 0.0020
938 DRUG-INDUCED LIVER INJURY 62 0.0020
939 ANGINA PECTORIS 56 0.0020
940 OSTEONECROSIS 64 0.0019
941 BLOOD GLUCOSE DECREASED 92 0.0019
942 TYPE 2 DIABETES MELLITUS 64 0.0019
943 DRUG INTERACTION 300 0.0019
944 FREQUENT BOWEL MOVEMENTS 51 0.0019
945 DEPRESSION 423 0.0019
946 LUNG NEOPLASM MALIGNANT 76 0.0018
947 FLATULENCE 104 0.0018
948 RESPIRATORY ARREST 50 0.0018
949 THERAPEUTIC RESPONSE UNEXPECTED 81 0.0018
950 GASTRIC DISORDER 60 0.0017
951 COLITIS ULCERATIVE 77 0.0017
952 DYSKINESIA 70 0.0017
953 EYE IRRITATION 99 0.0017
954 MULTIPLE SCLEROSIS 82 0.0017
955 PRODUCT DOSE OMISSION 110 0.0017
956 AGEUSIA 42 0.0017
957 CONVULSION 95 0.0017
958 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 75 0.0016
959 HYPERKALAEMIA 56 0.0016
960 BREAST CANCER 141 0.0015
961 MEDICATION ERROR 84 0.0015
962 HYPOGLYCAEMIA 73 0.0015
963 EXPIRED PRODUCT ADMINISTERED 49 0.0015
964 EMOTIONAL DISORDER 45 0.0015
965 THERAPEUTIC RESPONSE DECREASED 88 0.0014
966 ANGER 48 0.0014
967 DRUG EFFECT DECREASED 75 0.0014
968 DRY SKIN 182 0.0014
969 ADVERSE EVENT 124 0.0013
970 INJURY 94 0.0013
971 BLOOD CHOLESTEROL INCREASED 61 0.0013
972 NEOPLASM PROGRESSION 45 0.0013
973 ELECTROCARDIOGRAM QT PROLONGED 44 0.0012
974 PRODUCT SUBSTITUTION ISSUE 66 0.0011
975 AGGRESSION 57 0.0011
976 DEVICE DIFFICULT TO USE 69 0.0010
977 DYSGEUSIA 77 0.0010
978 SKIN BURNING SENSATION 71 0.0010
979 BLOOD GLUCOSE INCREASED 181 0.0010
980 HALLUCINATION 71 0.0009
981 DEVICE MALFUNCTION 66 0.0009
982 CHRONIC KIDNEY DISEASE 69 0.0009
983 DRUG DOSE OMISSION 132 0.0008
984 ACNE 58 0.0008
985 SUICIDAL IDEATION 68 0.0007
986 MALIGNANT NEOPLASM PROGRESSION 70 0.0007
987 PROSTATE CANCER 47 0.0006
988 INTENTIONAL PRODUCT MISUSE 51 0.0006
989 EMOTIONAL DISTRESS 67 0.0006
990 ACCIDENTAL EXPOSURE TO PRODUCT 56 0.0005
991 TOXICITY TO VARIOUS AGENTS 90 0.0005
992 OVERDOSE 109 0.0005
993 DRUG DEPENDENCE 45 0.0003